pegylated irinotecan NKTR-102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pegylated irinotecan NKTR-102, covering 2019-09-06 to 2019-09-06. Get the full timeline:
Most recent: Clinical Trial Update: Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 2]